BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

CAPS Rating: 1 out of 5

A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.

Recs

0
Player Avatar pchop123 (71.80) Submitted: 2/8/2012 3:34:14 PM : Underperform Start Price: $4.04 BCRX Score: -6.40

no no no

Featured Broker Partners


Advertisement